340B Supply Chain Partners Push Back Against Manufacturer Contract Pharmacy Requests

Note from Publisher and CEO Ted Slafsky: We are pleased that Bronwyn Mixter is filling in for Tom Mirga for the next two weeks while Tom takes a late summer break. Bronwyn is a veteran health care reporter who covered

Read More »

Breaking News

BREAKING: Novartis the Latest to Seek 340B Contract Pharmacy Claims Data

A Message from Publisher and CEO Ted Slafsky: I hope all is well. For now, we have more requests for 340B Report sponsorships than space available. Fortunately, we are creating a new website and newsletter platform that will accommodate our growing

Read More »

Breaking News

BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

Drug manufacturer AstraZeneca today sent letters to 340B covered entities and its wholesale pharmacy contacts telling them that, effective Oct. 1, it

Read More »

A Closer Look at Democratic VP Choice Harris’s Positions on the 340B Program

A Message from Publisher and CEO Ted Slafsky: Please join us in welcoming AllianceRx Walgreens Prime as the newest 340B Report sponsor. We are very pleased to have them on board. For now, we have more requests for sponsorships than space

Read More »

Health Centers Seek Meeting With Merck About its 340B Contract Pharmacy Data Request

A Message from Publisher and CEO Ted Slafsky: I encourage you all to read today’s sponsored content article from SPARx, a division of Comprehensive Pharmacy Services, about the importance of relationships with key stakeholders in hospital-based specialty pharmacy. The ability

Read More »

Hospitals Slam Proposal to Deepen Medicare Payment Cuts for 340B Drugs

Hospitals Slam Proposal to Deepen Medicare Payment Cuts for 340B Drugs

National hospital associations slammed the Trump administration’s proposal Tuesday to deepen Medicare Part B drug reimbursement cuts for 340B hospitals, saying the move would defy congressional intent and threaten

Read More »

After Big Win in Court, CMS Proposes Cutting 340B Drug Payments Even More

After Big Win in Court, CMS Proposes Cutting 340B Drug Payments Even More

Fresh off a major federal appeals court win, the U.S. Centers for Medicare & Medicaid Services (CMS) proposed this morning to cut Medicare Part B payments

Read More »

Could CMS Follow Up 340B Court Victory with Deeper Cuts for Hospitals?

Could CMS Follow Up 340B Court Victory with Deeper Cuts for Hospitals?

Yesterday’s federal appeals court ruling upholding the Trump administration’s nearly 30 percent cut in 340B hospitals’ Medicare Part B drug reimbursement raises the question of what to expect

Read More »

BREAKING: U.S. Appeals Court Upholds Deep Cuts in 340B Hospitals’ Medicare Part B Drug Reimbursement

Subscribe now

U.S. Appeals Court Upholds Deep Cuts in 340B Hospitals’ Medicare Part B Drug Reimbursement

The Trump administration’s nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital outpatient prospective payment system

Read More »

340B Bill Introduced in House; Senate 340B Bill Gets Two More Sponsors

340B Bill Introduced in House; Senate 340B Bill Gets Two More Sponsors

U.S. Reps. Doris Matsui (D-Calif.) and Chris Stewart (R-Utah) yesterday introduced their bill (H.R. 7838) to protect hospitals from losing eligibility for 340B drug discounts and to

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live